Molecular Weight:   | 296.14 |
Volume:   | 313.506 |
LogP:   | 5.945 |
LogD:   | 3.87 |
LogS:   | -3.916 |
# Rotatable Bonds:   | 0 |
TPSA:   | 53.6 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 2 |
# Rings:   | 4 |
# Heavy Atoms:   | 3 |
QED Drug-Likeness Score:   | 0.579 |
Synthetic Accessibility Score:   | 3.058 |
Fsp3:   | 0.368 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Rejected |
GSK Rule:   | Rejected |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Accepted |
Chelating Alert:   | 2 |
PAINS Alert:   | 1 |
Caco-2 Permeability:   | -4.877 |
MDCK Permeability:   | 1.666021671553608e-05 |
Pgp-inhibitor:   | 0.129 |
Pgp-substrate:   | 0.008 |
Human Intestinal Absorption (HIA):   | 0.035 |
20% Bioavailability (F20%):   | 0.128 |
30% Bioavailability (F30%):   | 0.051 |
Blood-Brain-Barrier Penetration (BBB):   | 0.037 |
Plasma Protein Binding (PPB):   | 98.59485626220703% |
Volume Distribution (VD):   | 1.997 |
Pgp-substrate:   | 3.677635669708252% |
CYP1A2-inhibitor:   | 0.92 |
CYP1A2-substrate:   | 0.801 |
CYP2C19-inhibitor:   | 0.637 |
CYP2C19-substrate:   | 0.08 |
CYP2C9-inhibitor:   | 0.615 |
CYP2C9-substrate:   | 0.828 |
CYP2D6-inhibitor:   | 0.43 |
CYP2D6-substrate:   | 0.852 |
CYP3A4-inhibitor:   | 0.141 |
CYP3A4-substrate:   | 0.144 |
Clearance (CL):   | 4.362 |
Half-life (T1/2):   | 0.19 |
hERG Blockers:   | 0.012 |
Human Hepatotoxicity (H-HT):   | 0.102 |
Drug-inuced Liver Injury (DILI):   | 0.822 |
AMES Toxicity:   | 0.173 |
Rat Oral Acute Toxicity:   | 0.754 |
Maximum Recommended Daily Dose:   | 0.226 |
Skin Sensitization:   | 0.914 |
Carcinogencity:   | 0.682 |
Eye Corrosion:   | 0.004 |
Eye Irritation:   | 0.881 |
Respiratory Toxicity:   | 0.792 |
Natural Product ID:   | NPC77000 |
Common Name*:   | Cryptotanshinone |
IUPAC Name:   | (1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[1,2-g][1]benzofuran-10,11-dione |
Synonyms:   | Cryptotanshinone |
Standard InCHIKey:   | GVKKJJOMQCNPGB-JTQLQIEISA-N |
Standard InCHI:   | InChI=1S/C19H20O3/c1-10-9-22-18-12-6-7-13-11(5-4-8-19(13,2)3)15(12)17(21)16(20)14(10)18/h6-7,10H,4-5,8-9H2,1-3H3/t10-/m0/s1 |
SMILES:   | C[C@H]1COC2=C1C(=O)C(=O)c1c3CCCC(C)(C)c3ccc21 |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL187460 |
PubChem CID:   |
160254 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | root | n.a. |
PMID[11374966] |
NPO22175 | Perovskia abrotanoides | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[11720520] |
NPO25701 | Amentotaxus yunnanensis | Species | Taxaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[12880325] |
NPO25779 | Vicia sativa | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[1567426] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[16038550] |
NPO25813 | Salvia przewalskii | Species | Lamiaceae | Eukaryota | n.a. | whole plant | n.a. |
PMID[17217287] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[17583950] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[18855446] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[20455578] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[21775156] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[23286284] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[24108414] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[27569393] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[29185738] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. |
PMID[30351923] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | root | n.a. |
PMID[3655791] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | roots | n.a. | n.a. |
PMID[9834151] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO25701 | Amentotaxus yunnanensis | Species | Taxaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO25813 | Salvia przewalskii | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO25779 | Vicia sativa | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
NPO25813 | Salvia przewalskii | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO24740 | Uvaria klaineana | Species | Annonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO25779 | Vicia sativa | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO25701 | Amentotaxus yunnanensis | Species | Taxaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO28257 | Dioscorea communis | Species | Dioscoreaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO25779 | Vicia sativa | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[TM-MC] |
NPO22175 | Perovskia abrotanoides | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO12800 | Glycine falcata | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25868 | Decachaeta ovatifolia | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[UNPD] |
NPO5743 | Salvia miltiorrhiza | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO26087 | Euphorbia retusa | Species | Euphorbiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO23960 | Artemisia siversiana | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO22758 | Picradeniopsis pringlei | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO11814 | Asphodeline tenuior | Species | Asphodelaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO26223 | Cladonia bellidiflora | Species | Cladoniaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO11003 | Euphorbia sancta | Species | Euphorbiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO23417 | Rhabdia lycioides | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[UNPD] |
NPO28257 | Dioscorea communis | Species | Dioscoreaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO6346 | Phallusia fumigata | Species | Ascidiidae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO11985 | Glycyrrhiza triphylla | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25701 | Amentotaxus yunnanensis | Species | Taxaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25974 | Streptomyces lateritius | Species | Streptomycetaceae | Bacteria | n.a. | n.a. | n.a. | Database[UNPD] |
NPO415 | Deguelia hatschbachii | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO11487 | Senecio madagascariensis | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO12476 | Delphinium cyphoplectrum | Species | Ranunculaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO24988 | Viburnum sieboldi | Species | Adoxaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO27437 | Camptothecium lutescens | Species | Brachytheciaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO28189 | Metzgeria pubescens | Species | Metzgeriaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25212 | Ritterella rubra | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25813 | Salvia przewalskii | Species | Lamiaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO4009 | Allochromatium minutissimum | Species | Chromatiaceae | Bacteria | n.a. | n.a. | n.a. | Database[UNPD] |
NPO10155 | Stauntonia obovatifoliola | Species | Lardizabalaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO6321 | Agathosma thymifolia | Species | Rutaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO14253 | Bothriocline longipes | Species | Asteraceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO191 | Amaranthus hybr | Species | Amaranthaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO22016 | 0tholaena dealbata | Species | Pteridaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO26316 | Pleurophycus gardneri | Species | Alariaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO26054 | Palmaria palmata | Species | Palmariaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO25779 | Vicia sativa | Species | Fabaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO10497 | Hydrolithon reinboldii | Species | Corallinaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO24740 | Uvaria klaineana | Species | Annonaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
NPO13164 | Iris hoogiana | Species | Iridaceae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT83 | Cell Line | MCF7 | Homo sapiens | ED50 | = | 0.41 | ug ml-1 | PMID[451047] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | ED50 | = | 0.16 | ug ml-1 | PMID[451047] |
NPT196 | Cell Line | AGS | Homo sapiens | IC50 | = | 13500.0 | nM | PMID[451048] |
NPT196 | Cell Line | AGS | Homo sapiens | IC50 | = | 10200.0 | nM | PMID[451048] |
NPT927 | Cell Line | PBMC | Homo sapiens | IC50 | = | 37400.0 | nM | PMID[451049] |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | CD50 | = | 9.12 | uM | PMID[451050] |
NPT65 | Cell Line | HepG2 | Homo sapiens | CD50 | = | 29.7 | uM | PMID[451050] |
NPT165 | Cell Line | HeLa | Homo sapiens | CD50 | = | 17.2 | uM | PMID[451050] |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | = | 50118.7 | nM | PMID[451053] |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 39810.7 | nM | PMID[451053] |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 17782.8 | nM | PMID[451053] |
NPT1038 | Individual Protein | Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 31622.8 | nM | PMID[451053] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 28183.8 | nM | PMID[451054] |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 12589.3 | nM | PMID[451053] |
NPT3 | Individual Protein | Thioredoxin glutathione reductase | Schistosoma mansoni | Potency | = | 3981.1 | nM | PMID[451053] |
NPT442 | Individual Protein | Ferritin light chain | Equus caballus | Potency | = | 50118.7 | nM | PMID[451054] |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 891.3 | nM | PMID[451053] |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 19905.4 | nM | PMID[451054] |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 7062.7 | nM | PMID[451053] |
NPT1416 | Individual Protein | Neuropeptide S receptor | Homo sapiens | Potency | = | 25118.9 | nM | PMID[451053] |
NPT1254 | Individual Protein | Streptokinase A | Streptococcus pyogenes serotype M1 | EC50 | = | 3953.0 | nM | PMID[451053] |
NPT1254 | Individual Protein | Streptokinase A | Streptococcus pyogenes serotype M1 | EC50 | = | 14816.0 | nM | PMID[451053] |
NPT59 | Individual Protein | DNA polymerase beta | Homo sapiens | Potency | = | 22387.2 | nM | PMID[451053] |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | n.a. | 31622.8 | nM | PMID[451053] |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 29092.9 | nM | PMID[451053] |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | n.a. | 39810.7 | nM | PMID[451054] |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | n.a. | 39810.7 | nM | PMID[451053] |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | n.a. | 14125.4 | nM | PMID[451053] |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | n.a. | 16353.5 | nM | PMID[451053] |
NPT783 | Cell Line | MIA PaCa-2 | Homo sapiens | IC50 | = | 5800.0 | nM | PMID[451056] |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | n.a. | 11220.2 | nM | PMID[451054] |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | n.a. | 28183.8 | nM | PMID[451053] |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | n.a. | 28183.8 | nM | PMID[451053] |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | n.a. | 79432.8 | nM | PMID[451053] |
NPT65 | Cell Line | HepG2 | Homo sapiens | Potency | n.a. | 10000.0 | nM | PMID[451053] |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | n.a. | 23778.1 | nM | PMID[451054] |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | n.a. | 4466.8 | nM | PMID[451053] |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | n.a. | 21331.3 | nM | PMID[451053] |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | CC50 | n.a. | 33380.0 | nM | PMID[451053] |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | n.a. | 1610.65 | nM | PMID[451057] |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | n.a. | 4365.16 | nM | PMID[451057] |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | n.a. | 1548.82 | nM | PMID[451057] |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | n.a. | 3597.49 | nM | PMID[451057] |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | n.a. | 4698.94 | nM | PMID[451057] |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | n.a. | 40831.94 | nM | PMID[451057] |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | n.a. | 2387.81 | nM | PMID[451057] |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | n.a. | 1352.07 | nM | PMID[451057] |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | n.a. | 3349.65 | nM | PMID[451057] |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | n.a. | 305.49 | nM | PMID[451057] |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | n.a. | 381.94 | nM | PMID[451057] |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | n.a. | 3605.79 | nM | PMID[451057] |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | n.a. | 18323.14 | nM | PMID[451057] |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | n.a. | 325.84 | nM | PMID[451057] |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | n.a. | 4236.43 | nM | PMID[451057] |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | n.a. | 3681.29 | nM | PMID[451057] |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | n.a. | 1995.26 | nM | PMID[451057] |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | n.a. | 2786.12 | nM | PMID[451057] |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | n.a. | 16069.41 | nM | PMID[451057] |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | n.a. | 2576.32 | nM | PMID[451057] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | n.a. | 11967.41 | nM | PMID[451057] |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | n.a. | 2517.68 | nM | PMID[451057] |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | n.a. | 8184.65 | nM | PMID[451057] |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | n.a. | 3419.79 | nM | PMID[451057] |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | n.a. | 1729.82 | nM | PMID[451057] |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | n.a. | 2009.09 | nM | PMID[451057] |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | n.a. | 2192.8 | nM | PMID[451057] |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | n.a. | 1032.76 | nM | PMID[451057] |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | n.a. | 1644.37 | nM | PMID[451057] |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | n.a. | 3311.31 | nM | PMID[451057] |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | n.a. | 12189.9 | nM | PMID[451057] |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | n.a. | 2517.68 | nM | PMID[451057] |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | n.a. | 2108.63 | nM | PMID[451057] |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | n.a. | 4246.2 | nM | PMID[451057] |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | n.a. | 1049.54 | nM | PMID[451057] |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | n.a. | 881.05 | nM | PMID[451057] |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | n.a. | 19952.6 | nM | PMID[451054] |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | n.a. | 23778.1 | nM | PMID[451053] |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | n.a. | 2483.13 | nM | PMID[451057] |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | n.a. | 1940.89 | nM | PMID[451057] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | n.a. | 2964.83 | nM | PMID[451057] |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | n.a. | 1901.08 | nM | PMID[451057] |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | n.a. | 2218.2 | nM | PMID[451057] |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | n.a. | 4623.81 | nM | PMID[451057] |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | n.a. | 11614.49 | nM | PMID[451057] |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | n.a. | 4931.74 | nM | PMID[451057] |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | n.a. | 9462.37 | nM | PMID[451057] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | n.a. | 1633.05 | nM | PMID[451057] |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | n.a. | 2032.36 | nM | PMID[451057] |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | n.a. | 1415.79 | nM | PMID[451057] |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | n.a. | 5804.8 | nM | PMID[451053] |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | n.a. | 8222.43 | nM | PMID[451057] |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | n.a. | 1678.8 | nM | PMID[451057] |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | n.a. | 2710.19 | nM | PMID[451057] |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | n.a. | 31622.8 | nM | PMID[451054] |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | n.a. | 15848.9 | nM | PMID[451053] |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | n.a. | 25118.9 | nM | PMID[451054] |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | n.a. | 2290.87 | nM | PMID[451057] |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | n.a. | 1954.34 | nM | PMID[451057] |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | n.a. | 3419.79 | nM | PMID[451057] |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | n.a. | 4305.27 | nM | PMID[451057] |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | n.a. | 3243.4 | nM | PMID[451057] |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | n.a. | 2182.73 | nM | PMID[451057] |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | n.a. | 3191.54 | nM | PMID[451057] |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | n.a. | 6295.06 | nM | PMID[451057] |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | n.a. | 1148.15 | nM | PMID[451057] |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | n.a. | 18356.4 | nM | PMID[451053] |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | n.a. | 4109.5 | nM | PMID[451053] |
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | n.a. | 28183.8 | nM | PMID[451053] |
NPT200 | Individual Protein | SARS coronavirus 3C-like proteinase | SARS coronavirus | IC50 | = | 226700.0 | nM | PMID[451058] |
NPT200 | Individual Protein | SARS coronavirus 3C-like proteinase | SARS coronavirus | IC50 | = | 800.0 | nM | PMID[451058] |
NPT200 | Individual Protein | SARS coronavirus 3C-like proteinase | SARS coronavirus | Ki | = | 9000.0 | nM | PMID[451058] |
NPT200 | Individual Protein | SARS coronavirus 3C-like proteinase | SARS coronavirus | IC50 | = | 87600.0 | nM | PMID[451058] |
NPT201 | Individual Protein | Papain | Carica papaya | IC50 | = | 89800.0 | nM | PMID[451058] |
NPT202 | Individual Protein | Protease | Human immunodeficiency virus 1 | IC50 | = | 69600.0 | nM | PMID[451058] |
NPT200 | Individual Protein | SARS coronavirus 3C-like proteinase | SARS coronavirus | IC50 | = | 10100.0 | nM | PMID[451058] |
NPT144 | Individual Protein | Telomerase reverse transcriptase | Homo sapiens | Inhibition | = | 75.0 | % | PMID[451059] |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 3.33 | % | PMID[451060] |
NPT38 | Individual Protein | Signal transducer and activator of transcription 3 | Homo sapiens | IC50 | = | 4600.0 | nM | PMID[451061] |
NPT933 | Cell Line | U373 MG | Homo sapiens | FC | = | 4.5 | n.a. | PMID[451063] |
NPT203 | Individual Protein | Carboxylesterase 2 | Homo sapiens | Inhibition | = | 81.0 | % | PMID[451063] |
NPT204 | Individual Protein | Acetylcholinesterase | Homo sapiens | Ki | > | 100000.0 | nM | PMID[451063] |
NPT204 | Individual Protein | Acetylcholinesterase | Homo sapiens | Ki | = | 6410.0 | nM | PMID[451063] |
NPT203 | Individual Protein | Carboxylesterase 2 | Homo sapiens | Ki | = | 290.0 | nM | PMID[451063] |
NPT203 | Individual Protein | Carboxylesterase 2 | Homo sapiens | Ki | = | 141.0 | nM | PMID[451063] |
NPT166 | Individual Protein | Acyl coenzyme A:cholesterol acyltransferase | Homo sapiens | Ki | = | 544.0 | nM | PMID[451063] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 5173.5 | nM | PMID[451053] |
NPT206 | Individual Protein | Protein-tyrosine phosphatase 2C | Homo sapiens | IC50 | = | 23900.0 | nM | PMID[451064] |
NPT206 | Individual Protein | Protein-tyrosine phosphatase 2C | Homo sapiens | IC50 | = | 45180.0 | nM | PMID[451064] |
NPT206 | Individual Protein | Protein-tyrosine phosphatase 2C | Homo sapiens | Kcat/Km | = | 2.15 | /mM/s | PMID[451064] |
NPT206 | Individual Protein | Protein-tyrosine phosphatase 2C | Homo sapiens | Kcat | = | 0.36 | /s | PMID[451064] |
NPT206 | Individual Protein | Protein-tyrosine phosphatase 2C | Homo sapiens | Km | = | 170000.0 | nM | PMID[451064] |
NPT206 | Individual Protein | Protein-tyrosine phosphatase 2C | Homo sapiens | Vmax | = | 6.96 | microM/min | PMID[451064] |
NPT1210 | Individual Protein | T-cell protein-tyrosine phosphatase | Homo sapiens | IC50 | = | 55700.0 | nM | PMID[451064] |
NPT3914 | Individual Protein | Tyrosine-protein phosphatase non-receptor type 9 | Homo sapiens | IC50 | = | 59400.0 | nM | PMID[451064] |
NPT1870 | Individual Protein | Receptor-type tyrosine-protein phosphatase F (LAR) | Homo sapiens | IC50 | = | 36900.0 | nM | PMID[451064] |
NPT287 | Individual Protein | Leukocyte common antigen | Homo sapiens | IC50 | = | 41400.0 | nM | PMID[451064] |
NPT178 | Individual Protein | Protein-tyrosine phosphatase 1B | Homo sapiens | IC50 | = | 33500.0 | nM | PMID[451064] |
NPT205 | Individual Protein | Protein-tyrosine phosphatase 1C | Homo sapiens | IC50 | = | 39500.0 | nM | PMID[451064] |
NPT206 | Individual Protein | Protein-tyrosine phosphatase 2C | Homo sapiens | IC50 | = | 22500.0 | nM | PMID[451064] |
NPT38 | Individual Protein | Signal transducer and activator of transcription 3 | Homo sapiens | Inhibition | = | 25.0 | % | PMID[451066] |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | n.a. | 31622.8 | nM | PMID[451053] |
NPT446 | Individual Protein | Rap guanine nucleotide exchange factor 3 | Homo sapiens | Potency | n.a. | 100000.0 | nM | PMID[451053] |
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | n.a. | 44668.4 | nM | PMID[451053] |
NPT446 | Individual Protein | Rap guanine nucleotide exchange factor 3 | Homo sapiens | Potency | n.a. | 44668.4 | nM | PMID[451053] |
NPT38 | Individual Protein | Signal transducer and activator of transcription 3 | Homo sapiens | Inhibition | = | 85.0 | % | PMID[451067] |
NPT38 | Individual Protein | Signal transducer and activator of transcription 3 | Homo sapiens | Inhibition | = | 78.0 | % | PMID[451067] |
NPT21802 | PROTEIN FAMILY | Hypoxia inducible factors; HIF-1-alpha, HIF-2-alpha | Homo sapiens | IC50 | = | 1580.0 | nM | PMID[451048] |
NPT21802 | PROTEIN FAMILY | Hypoxia inducible factors; HIF-1-alpha, HIF-2-alpha | Homo sapiens | IC50 | = | 1360.0 | nM | PMID[451048] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | > | 30000.0 | nM | PMID[451048] |
NPT841 | Organism | Leishmania major | Leishmania major | IC50 | = | 18400.0 | nM | PMID[451049] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 12500.0 | nM | PMID[451049] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 6900.0 | nM | PMID[451049] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 7500.0 | nM | PMID[451049] |
NPT3912 | Tissue | Artery | Sus scrofa | ED50 | = | -7.2 | ug ml-1 | PMID[451051] |
NPT3912 | Tissue | Artery | Sus scrofa | Emax | = | 64.9 | % | PMID[451051] |
NPT27 | Others | Unspecified | EC50 | = | 22900.0 | nM | PMID[451052] | |
NPT668 | Individual Protein | P-glycoprotein 1 | Homo sapiens | Inhibition | = | 50.0 | % | PMID[451052] |
NPT174 | Organism | Streptococcus | Streptococcus | EC50 | = | 14089.0 | nM | PMID[451053] |
NPT1252 | Organism | Streptococcus sp. 'group A' | Streptococcus sp. 'group A' | EC50 | = | 5172.0 | nM | PMID[451053] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 12589.3 | nM | PMID[451053] |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 31622.8 | nM | PMID[451054] |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 14125.4 | nM | PMID[451053] |
NPT864 | Individual Protein | Lethal(3)malignant brain tumor-like protein 1 | Homo sapiens | Potency | = | 17782.8 | nM | PMID[451053] |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | n.a. | 25118.9 | nM | PMID[451053] |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | n.a. | 12589.3 | nM | PMID[451054] |
NPT2 | Others | Unspecified | Inhibition | = | 43.7 | % | PMID[451055] | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 18526.0 | nM | PMID[451053] |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | n.a. | 22387.2 | nM | PMID[451053] |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | n.a. | 28183.8 | nM | PMID[451053] |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | n.a. | 14125.4 | nM | PMID[451053] |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | n.a. | 56234.1 | nM | PMID[451053] |
NPT9 | Individual Protein | DNA polymerase eta | Homo sapiens | Potency | n.a. | 35481.3 | nM | PMID[451053] |
NPT917 | Individual Protein | Dengue virus type 2 NS3 protein | Dengue virus type 2 (strain Thailand/16681/1984) (DENV-2) | IC50 | n.a. | 90060.0 | nM | PMID[451053] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 2936.2 | nM | PMID[451053] |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | n.a. | 50118.7 | nM | PMID[451053] |
NPT2 | Others | Unspecified | Potency | n.a. | 2818.4 | nM | PMID[451053] | |
NPT821 | Individual Protein | Werner syndrome ATP-dependent helicase | Homo sapiens | Potency | n.a. | 56234.1 | nM | PMID[451053] |
NPT2 | Others | Unspecified | IC50 | = | 119800.0 | nM | PMID[451058] | |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 12.06 | % | PMID[451060] |
NPT68 | Individual Protein | Aldose reductase | Rattus norvegicus | IC50 | = | 4786.3 | nM | PMID[451062] |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | n.a. | 20596.2 | nM | PMID[451053] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | = | 17220.0 | nM | PMID[451064] |
NPT2 | Others | Unspecified | Ratio IC50 | = | 2.01 | n.a. | PMID[451064] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 1.89 | n.a. | PMID[451064] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 2.48 | n.a. | PMID[451064] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 2.64 | n.a. | PMID[451064] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 1.64 | n.a. | PMID[451064] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 1.84 | n.a. | PMID[451064] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 1.49 | n.a. | PMID[451064] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 1.76 | n.a. | PMID[451064] | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | F | = | 10.6 | % | PMID[451065] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | F | = | 2.1 | % | PMID[451065] |
NPT2 | Others | Unspecified | Potency | n.a. | 11220.2 | nM | PMID[451053] | |
NPT2 | Others | Unspecified | Potency | n.a. | 28183.8 | nM | PMID[451053] | |
NPT831 | Individual Protein | Serine/threonine-protein kinase PLK1 | Homo sapiens | Potency | n.a. | 26679.5 | nM | PMID[451053] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 6.24 | % | PMID[451068] |
NPT20556 | SINGLE PROTEIN | Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 45.85 | % | PMID[451069] |
NPT20556 | SINGLE PROTEIN | Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | -10.15 | % | PMID[451070] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | -0.02 | % | PMID[451071] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 1.43 | % | PMID[451072] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC77000 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC238861 |
0.9655 | High Similarity | NPC51079 |
0.9478 | High Similarity | NPC988 |
0.9478 | High Similarity | NPC289432 |
0.9397 | High Similarity | NPC144547 |
0.9211 | High Similarity | NPC135730 |
0.9123 | High Similarity | NPC228936 |
0.8983 | High Similarity | NPC232958 |
0.8947 | High Similarity | NPC13784 |
0.8889 | High Similarity | NPC310662 |
0.8879 | High Similarity | NPC226093 |
0.887 | High Similarity | NPC196075 |
0.8793 | High Similarity | NPC474095 |
0.8707 | High Similarity | NPC477411 |
0.8527 | High Similarity | NPC212207 |
0.839 | Intermediate Similarity | NPC326664 |
0.8376 | Intermediate Similarity | NPC212415 |
0.832 | Intermediate Similarity | NPC295664 |
0.8319 | Intermediate Similarity | NPC470764 |
0.8264 | Intermediate Similarity | NPC80605 |
0.8264 | Intermediate Similarity | NPC323440 |
0.8264 | Intermediate Similarity | NPC222968 |
0.8244 | Intermediate Similarity | NPC23894 |
0.8235 | Intermediate Similarity | NPC241851 |
0.8189 | Intermediate Similarity | NPC51292 |
0.8182 | Intermediate Similarity | NPC309056 |
0.8167 | Intermediate Similarity | NPC474408 |
0.8154 | Intermediate Similarity | NPC239134 |
0.8151 | Intermediate Similarity | NPC143768 |
0.8145 | Intermediate Similarity | NPC50872 |
0.8145 | Intermediate Similarity | NPC472981 |
0.814 | Intermediate Similarity | NPC471832 |
0.8136 | Intermediate Similarity | NPC210089 |
0.8125 | Intermediate Similarity | NPC115797 |
0.8125 | Intermediate Similarity | NPC51448 |
0.8115 | Intermediate Similarity | NPC45794 |
0.8115 | Intermediate Similarity | NPC61651 |
0.811 | Intermediate Similarity | NPC476599 |
0.8106 | Intermediate Similarity | NPC474659 |
0.8095 | Intermediate Similarity | NPC328107 |
0.8017 | Intermediate Similarity | NPC221275 |
0.8015 | Intermediate Similarity | NPC164295 |
0.8 | Intermediate Similarity | NPC128368 |
0.8 | Intermediate Similarity | NPC131684 |
0.7984 | Intermediate Similarity | NPC204784 |
0.7984 | Intermediate Similarity | NPC478162 |
0.7984 | Intermediate Similarity | NPC478165 |
0.7983 | Intermediate Similarity | NPC265513 |
0.7983 | Intermediate Similarity | NPC137315 |
0.7983 | Intermediate Similarity | NPC474057 |
0.7955 | Intermediate Similarity | NPC472656 |
0.7955 | Intermediate Similarity | NPC183103 |
0.7953 | Intermediate Similarity | NPC85511 |
0.7934 | Intermediate Similarity | NPC307651 |
0.7926 | Intermediate Similarity | NPC119542 |
0.792 | Intermediate Similarity | NPC473243 |
0.792 | Intermediate Similarity | NPC476225 |
0.7917 | Intermediate Similarity | NPC79496 |
0.7917 | Intermediate Similarity | NPC471188 |
0.7917 | Intermediate Similarity | NPC280789 |
0.7903 | Intermediate Similarity | NPC318173 |
0.7899 | Intermediate Similarity | NPC273837 |
0.7895 | Intermediate Similarity | NPC203486 |
0.7895 | Intermediate Similarity | NPC329913 |
0.7891 | Intermediate Similarity | NPC75432 |
0.7881 | Intermediate Similarity | NPC470391 |
0.7879 | Intermediate Similarity | NPC472394 |
0.7869 | Intermediate Similarity | NPC210092 |
0.7852 | Intermediate Similarity | NPC471670 |
0.7851 | Intermediate Similarity | NPC470253 |
0.7846 | Intermediate Similarity | NPC428300 |
0.784 | Intermediate Similarity | NPC202015 |
0.7833 | Intermediate Similarity | NPC291799 |
0.7833 | Intermediate Similarity | NPC474157 |
0.7829 | Intermediate Similarity | NPC328997 |
0.7829 | Intermediate Similarity | NPC470765 |
0.7829 | Intermediate Similarity | NPC294050 |
0.7823 | Intermediate Similarity | NPC228318 |
0.7815 | Intermediate Similarity | NPC83628 |
0.7815 | Intermediate Similarity | NPC265407 |
0.7812 | Intermediate Similarity | NPC318067 |
0.7803 | Intermediate Similarity | NPC470278 |
0.7797 | Intermediate Similarity | NPC30594 |
0.7797 | Intermediate Similarity | NPC37622 |
0.7795 | Intermediate Similarity | NPC167323 |
0.7795 | Intermediate Similarity | NPC269923 |
0.7787 | Intermediate Similarity | NPC67377 |
0.7787 | Intermediate Similarity | NPC196673 |
0.7769 | Intermediate Similarity | NPC474737 |
0.7769 | Intermediate Similarity | NPC470753 |
0.7769 | Intermediate Similarity | NPC270699 |
0.7769 | Intermediate Similarity | NPC473220 |
0.7769 | Intermediate Similarity | NPC82899 |
0.7769 | Intermediate Similarity | NPC169913 |
0.7761 | Intermediate Similarity | NPC59459 |
0.7761 | Intermediate Similarity | NPC126516 |
0.776 | Intermediate Similarity | NPC254233 |
0.7752 | Intermediate Similarity | NPC472693 |
0.7752 | Intermediate Similarity | NPC472694 |
0.775 | Intermediate Similarity | NPC214067 |
0.775 | Intermediate Similarity | NPC196246 |
0.7746 | Intermediate Similarity | NPC478163 |
0.7744 | Intermediate Similarity | NPC279596 |
0.7744 | Intermediate Similarity | NPC477412 |
0.7742 | Intermediate Similarity | NPC190298 |
0.7731 | Intermediate Similarity | NPC203732 |
0.7727 | Intermediate Similarity | NPC147561 |
0.7727 | Intermediate Similarity | NPC57552 |
0.7727 | Intermediate Similarity | NPC82712 |
0.7724 | Intermediate Similarity | NPC215419 |
0.7719 | Intermediate Similarity | NPC239185 |
0.7717 | Intermediate Similarity | NPC97566 |
0.7712 | Intermediate Similarity | NPC209632 |
0.7712 | Intermediate Similarity | NPC471186 |
0.771 | Intermediate Similarity | NPC316553 |
0.7698 | Intermediate Similarity | NPC476645 |
0.7692 | Intermediate Similarity | NPC236405 |
0.7692 | Intermediate Similarity | NPC275576 |
0.7692 | Intermediate Similarity | NPC9180 |
0.7692 | Intermediate Similarity | NPC100402 |
0.7687 | Intermediate Similarity | NPC165612 |
0.7687 | Intermediate Similarity | NPC476644 |
0.7686 | Intermediate Similarity | NPC1082 |
0.7686 | Intermediate Similarity | NPC167504 |
0.7686 | Intermediate Similarity | NPC305912 |
0.768 | Intermediate Similarity | NPC152812 |
0.7676 | Intermediate Similarity | NPC281398 |
0.7674 | Intermediate Similarity | NPC325740 |
0.7674 | Intermediate Similarity | NPC472704 |
0.7669 | Intermediate Similarity | NPC72915 |
0.7667 | Intermediate Similarity | NPC17417 |
0.7667 | Intermediate Similarity | NPC469636 |
0.7667 | Intermediate Similarity | NPC10251 |
0.7661 | Intermediate Similarity | NPC471616 |
0.7661 | Intermediate Similarity | NPC260886 |
0.766 | Intermediate Similarity | NPC245522 |
0.766 | Intermediate Similarity | NPC114513 |
0.766 | Intermediate Similarity | NPC290038 |
0.7652 | Intermediate Similarity | NPC59502 |
0.7652 | Intermediate Similarity | NPC134882 |
0.7647 | Intermediate Similarity | NPC472551 |
0.7647 | Intermediate Similarity | NPC472545 |
0.7642 | Intermediate Similarity | NPC471721 |
0.7634 | Intermediate Similarity | NPC177925 |
0.763 | Intermediate Similarity | NPC470406 |
0.7627 | Intermediate Similarity | NPC114594 |
0.7623 | Intermediate Similarity | NPC292834 |
0.7609 | Intermediate Similarity | NPC475400 |
0.7606 | Intermediate Similarity | NPC478160 |
0.7606 | Intermediate Similarity | NPC478166 |
0.7603 | Intermediate Similarity | NPC251854 |
0.7603 | Intermediate Similarity | NPC93084 |
0.7597 | Intermediate Similarity | NPC472703 |
0.7594 | Intermediate Similarity | NPC49272 |
0.7591 | Intermediate Similarity | NPC39549 |
0.7591 | Intermediate Similarity | NPC232996 |
0.7591 | Intermediate Similarity | NPC307401 |
0.7589 | Intermediate Similarity | NPC478164 |
0.7589 | Intermediate Similarity | NPC117674 |
0.7586 | Intermediate Similarity | NPC476042 |
0.7583 | Intermediate Similarity | NPC56493 |
0.7583 | Intermediate Similarity | NPC470007 |
0.7583 | Intermediate Similarity | NPC112903 |
0.7581 | Intermediate Similarity | NPC93181 |
0.7576 | Intermediate Similarity | NPC72667 |
0.7574 | Intermediate Similarity | NPC473399 |
0.7574 | Intermediate Similarity | NPC473216 |
0.7569 | Intermediate Similarity | NPC192069 |
0.7569 | Intermediate Similarity | NPC95526 |
0.7565 | Intermediate Similarity | NPC265220 |
0.7561 | Intermediate Similarity | NPC469547 |
0.7561 | Intermediate Similarity | NPC272524 |
0.7561 | Intermediate Similarity | NPC93287 |
0.7557 | Intermediate Similarity | NPC121272 |
0.7557 | Intermediate Similarity | NPC470818 |
0.7556 | Intermediate Similarity | NPC477406 |
0.7556 | Intermediate Similarity | NPC477407 |
0.7554 | Intermediate Similarity | NPC470407 |
0.7542 | Intermediate Similarity | NPC89886 |
0.7542 | Intermediate Similarity | NPC60679 |
0.7542 | Intermediate Similarity | NPC301943 |
0.7542 | Intermediate Similarity | NPC474365 |
0.7542 | Intermediate Similarity | NPC247976 |
0.7541 | Intermediate Similarity | NPC475002 |
0.7541 | Intermediate Similarity | NPC95126 |
0.754 | Intermediate Similarity | NPC268930 |
0.7538 | Intermediate Similarity | NPC178382 |
0.7536 | Intermediate Similarity | NPC186647 |
0.7536 | Intermediate Similarity | NPC472395 |
0.7536 | Intermediate Similarity | NPC471542 |
0.7536 | Intermediate Similarity | NPC472371 |
0.7536 | Intermediate Similarity | NPC118366 |
0.7535 | Intermediate Similarity | NPC471451 |
0.7521 | Intermediate Similarity | NPC474364 |
0.7521 | Intermediate Similarity | NPC99846 |
0.7521 | Intermediate Similarity | NPC70624 |
0.7521 | Intermediate Similarity | NPC269023 |
0.7521 | Intermediate Similarity | NPC109514 |
0.7521 | Intermediate Similarity | NPC476993 |
0.7521 | Intermediate Similarity | NPC192577 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC77000 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD3412 | Clinical (unspecified phase) |
0.8376 | Intermediate Similarity | NPD1609 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD7457 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD5952 | Clinical (unspecified phase) |
0.7983 | Intermediate Similarity | NPD2181 | Clinical (unspecified phase) |
0.7734 | Intermediate Similarity | NPD3972 | Approved |
0.7727 | Intermediate Similarity | NPD7008 | Discontinued |
0.7724 | Intermediate Similarity | NPD5951 | Approved |
0.7719 | Intermediate Similarity | NPD3495 | Discontinued |
0.7667 | Intermediate Similarity | NPD2182 | Approved |
0.7519 | Intermediate Similarity | NPD6287 | Discontinued |
0.75 | Intermediate Similarity | NPD7163 | Clinical (unspecified phase) |
0.7481 | Intermediate Similarity | NPD1876 | Approved |
0.7422 | Intermediate Similarity | NPD1651 | Approved |
0.7419 | Intermediate Similarity | NPD6858 | Approved |
0.7419 | Intermediate Similarity | NPD7094 | Approved |
0.7398 | Intermediate Similarity | NPD4141 | Clinical (unspecified phase) |
0.7343 | Intermediate Similarity | NPD7236 | Approved |
0.7333 | Intermediate Similarity | NPD164 | Approved |
0.7324 | Intermediate Similarity | NPD7003 | Approved |
0.7288 | Intermediate Similarity | NPD1238 | Approved |
0.7252 | Intermediate Similarity | NPD1281 | Approved |
0.7236 | Intermediate Similarity | NPD6831 | Clinical (unspecified phase) |
0.7234 | Intermediate Similarity | NPD2346 | Discontinued |
0.7231 | Intermediate Similarity | NPD2932 | Approved |
0.7226 | Intermediate Similarity | NPD7713 | Phase 3 |
0.7226 | Intermediate Similarity | NPD8032 | Phase 2 |
0.7211 | Intermediate Similarity | NPD7239 | Suspended |
0.7197 | Intermediate Similarity | NPD4878 | Approved |
0.7192 | Intermediate Similarity | NPD6273 | Approved |
0.719 | Intermediate Similarity | NPD5909 | Discontinued |
0.7177 | Intermediate Similarity | NPD2067 | Discontinued |
0.7174 | Intermediate Similarity | NPD2979 | Phase 3 |
0.7154 | Intermediate Similarity | NPD3024 | Approved |
0.7154 | Intermediate Similarity | NPD3025 | Approved |
0.7132 | Intermediate Similarity | NPD7055 | Discontinued |
0.7113 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7111 | Intermediate Similarity | NPD2798 | Approved |
0.7109 | Intermediate Similarity | NPD3317 | Approved |
0.7107 | Intermediate Similarity | NPD1931 | Clinical (unspecified phase) |
0.7107 | Intermediate Similarity | NPD1929 | Approved |
0.7107 | Intermediate Similarity | NPD1930 | Approved |
0.7099 | Intermediate Similarity | NPD3019 | Approved |
0.709 | Intermediate Similarity | NPD1283 | Approved |
0.7087 | Intermediate Similarity | NPD1241 | Discontinued |
0.7077 | Intermediate Similarity | NPD7009 | Phase 2 |
0.7069 | Intermediate Similarity | NPD7631 | Approved |
0.7047 | Intermediate Similarity | NPD7458 | Discontinued |
0.7045 | Intermediate Similarity | NPD3023 | Approved |
0.7045 | Intermediate Similarity | NPD3026 | Approved |
0.7034 | Intermediate Similarity | NPD1989 | Approved |
0.7031 | Intermediate Similarity | NPD690 | Clinical (unspecified phase) |
0.7031 | Intermediate Similarity | NPD2629 | Approved |
0.7023 | Intermediate Similarity | NPD5691 | Approved |
0.7 | Intermediate Similarity | NPD2066 | Phase 3 |
0.7 | Intermediate Similarity | NPD7610 | Discontinued |
0.6993 | Remote Similarity | NPD1471 | Phase 3 |
0.6992 | Remote Similarity | NPD1547 | Clinical (unspecified phase) |
0.6985 | Remote Similarity | NPD6007 | Clinical (unspecified phase) |
0.6983 | Remote Similarity | NPD7609 | Phase 3 |
0.6977 | Remote Similarity | NPD4198 | Discontinued |
0.6972 | Remote Similarity | NPD2799 | Discontinued |
0.6966 | Remote Similarity | NPD4628 | Phase 3 |
0.6923 | Remote Similarity | NPD2531 | Phase 2 |
0.6923 | Remote Similarity | NPD2438 | Suspended |
0.6911 | Remote Similarity | NPD1237 | Approved |
0.6906 | Remote Similarity | NPD2313 | Discontinued |
0.6906 | Remote Similarity | NPD3764 | Approved |
0.6889 | Remote Similarity | NPD5327 | Phase 3 |
0.6875 | Remote Similarity | NPD7702 | Clinical (unspecified phase) |
0.6857 | Remote Similarity | NPD6663 | Approved |
0.6857 | Remote Similarity | NPD7961 | Discontinued |
0.6849 | Remote Similarity | NPD8166 | Discontinued |
0.6835 | Remote Similarity | NPD6039 | Approved |
0.6822 | Remote Similarity | NPD6010 | Discontinued |
0.6821 | Remote Similarity | NPD6591 | Clinical (unspecified phase) |
0.6821 | Remote Similarity | NPD5808 | Clinical (unspecified phase) |
0.6821 | Remote Similarity | NPD3226 | Approved |
0.6818 | Remote Similarity | NPD5616 | Clinical (unspecified phase) |
0.6818 | Remote Similarity | NPD7741 | Discontinued |
0.6812 | Remote Similarity | NPD5736 | Approved |
0.6806 | Remote Similarity | NPD2796 | Approved |
0.6791 | Remote Similarity | NPD4879 | Approved |
0.6788 | Remote Similarity | NPD3267 | Approved |
0.6788 | Remote Similarity | NPD3266 | Approved |
0.6783 | Remote Similarity | NPD650 | Approved |
0.6781 | Remote Similarity | NPD7421 | Clinical (unspecified phase) |
0.6774 | Remote Similarity | NPD7057 | Phase 3 |
0.6774 | Remote Similarity | NPD7058 | Phase 2 |
0.6767 | Remote Similarity | NPD4196 | Clinical (unspecified phase) |
0.6767 | Remote Similarity | NPD5585 | Approved |
0.6748 | Remote Similarity | NPD1932 | Approved |
0.6741 | Remote Similarity | NPD1201 | Approved |
0.6739 | Remote Similarity | NPD2788 | Approved |
0.6736 | Remote Similarity | NPD3748 | Approved |
0.6716 | Remote Similarity | NPD5126 | Approved |
0.6716 | Remote Similarity | NPD4626 | Approved |
0.6716 | Remote Similarity | NPD5125 | Phase 3 |
0.6716 | Remote Similarity | NPD17 | Approved |
0.6694 | Remote Similarity | NPD5700 | Clinical (unspecified phase) |
0.6693 | Remote Similarity | NPD2329 | Discontinued |
0.669 | Remote Similarity | NPD4307 | Phase 2 |
0.669 | Remote Similarity | NPD6100 | Approved |
0.669 | Remote Similarity | NPD4140 | Approved |
0.669 | Remote Similarity | NPD6099 | Approved |
0.6667 | Remote Similarity | NPD1693 | Approved |
0.6667 | Remote Similarity | NPD2532 | Approved |
0.6667 | Remote Similarity | NPD1470 | Approved |
0.6667 | Remote Similarity | NPD2533 | Approved |
0.6667 | Remote Similarity | NPD2534 | Approved |
0.6667 | Remote Similarity | NPD2797 | Approved |
0.6667 | Remote Similarity | NPD3268 | Approved |
0.6667 | Remote Similarity | NPD2800 | Approved |
0.6645 | Remote Similarity | NPD7819 | Suspended |
0.6644 | Remote Similarity | NPD2344 | Approved |
0.6643 | Remote Similarity | NPD6832 | Phase 2 |
0.6639 | Remote Similarity | NPD1088 | Approved |
0.6638 | Remote Similarity | NPD1087 | Approved |
0.6621 | Remote Similarity | NPD7305 | Phase 1 |
0.6619 | Remote Similarity | NPD5740 | Clinical (unspecified phase) |
0.6619 | Remote Similarity | NPD6085 | Phase 2 |
0.6583 | Remote Similarity | NPD1202 | Approved |
0.6583 | Remote Similarity | NPD5122 | Clinical (unspecified phase) |
0.6577 | Remote Similarity | NPD3295 | Clinical (unspecified phase) |
0.6575 | Remote Similarity | NPD4476 | Approved |
0.6575 | Remote Similarity | NPD4477 | Approved |
0.6573 | Remote Similarity | NPD3142 | Approved |
0.6573 | Remote Similarity | NPD3140 | Approved |
0.6571 | Remote Similarity | NPD7084 | Phase 3 |
0.6569 | Remote Similarity | NPD1608 | Approved |
0.6567 | Remote Similarity | NPD9545 | Approved |
0.6558 | Remote Similarity | NPD6599 | Discontinued |
0.6558 | Remote Similarity | NPD7028 | Phase 2 |
0.6556 | Remote Similarity | NPD7004 | Clinical (unspecified phase) |
0.6556 | Remote Similarity | NPD4378 | Clinical (unspecified phase) |
0.6541 | Remote Similarity | NPD5494 | Approved |
0.6541 | Remote Similarity | NPD405 | Clinical (unspecified phase) |
0.6529 | Remote Similarity | NPD688 | Clinical (unspecified phase) |
0.6528 | Remote Similarity | NPD4618 | Approved |
0.6528 | Remote Similarity | NPD4622 | Approved |
0.6522 | Remote Similarity | NPD4359 | Approved |
0.6515 | Remote Similarity | NPD4766 | Approved |
0.651 | Remote Similarity | NPD3750 | Approved |
0.651 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6508 | Remote Similarity | NPD3048 | Approved |
0.6508 | Remote Similarity | NPD3046 | Approved |
0.6508 | Remote Similarity | NPD3047 | Approved |
0.6507 | Remote Similarity | NPD4308 | Phase 3 |
0.6507 | Remote Similarity | NPD1509 | Clinical (unspecified phase) |
0.6503 | Remote Similarity | NPD7799 | Discontinued |
0.65 | Remote Similarity | NPD1508 | Approved |
0.65 | Remote Similarity | NPD4624 | Approved |
0.65 | Remote Similarity | NPD6959 | Discontinued |
0.6497 | Remote Similarity | NPD8443 | Clinical (unspecified phase) |
0.6497 | Remote Similarity | NPD5978 | Approved |
0.6497 | Remote Similarity | NPD5977 | Approved |
0.6493 | Remote Similarity | NPD6065 | Approved |
0.6483 | Remote Similarity | NPD6651 | Approved |
0.6483 | Remote Similarity | NPD3528 | Clinical (unspecified phase) |
0.6483 | Remote Similarity | NPD1607 | Approved |
0.6475 | Remote Similarity | NPD2199 | Approved |
0.6475 | Remote Similarity | NPD5667 | Approved |
0.6475 | Remote Similarity | NPD2198 | Approved |
0.6471 | Remote Similarity | NPD3672 | Approved |
0.6471 | Remote Similarity | NPD1090 | Approved |
0.6471 | Remote Similarity | NPD1086 | Approved |
0.6471 | Remote Similarity | NPD1778 | Approved |
0.6471 | Remote Similarity | NPD3673 | Approved |
0.6471 | Remote Similarity | NPD1089 | Approved |
0.6467 | Remote Similarity | NPD2309 | Approved |
0.6463 | Remote Similarity | NPD2935 | Discontinued |
0.6458 | Remote Similarity | NPD3373 | Approved |
0.6449 | Remote Similarity | NPD6637 | Approved |
0.6447 | Remote Similarity | NPD7422 | Clinical (unspecified phase) |
0.6446 | Remote Similarity | NPD1563 | Approved |
0.6444 | Remote Similarity | NPD3091 | Approved |
0.6444 | Remote Similarity | NPD2106 | Clinical (unspecified phase) |
0.6442 | Remote Similarity | NPD7473 | Discontinued |
0.6438 | Remote Similarity | NPD5688 | Approved |
0.6438 | Remote Similarity | NPD5689 | Approved |
0.6429 | Remote Similarity | NPD6647 | Phase 2 |
0.6423 | Remote Similarity | NPD3897 | Approved |
0.6423 | Remote Similarity | NPD3898 | Approved |
0.6423 | Remote Similarity | NPD3896 | Approved |
0.6423 | Remote Similarity | NPD3895 | Approved |
0.6418 | Remote Similarity | NPD4230 | Clinical (unspecified phase) |
0.6414 | Remote Similarity | NPD5735 | Approved |
0.6414 | Remote Similarity | NPD6355 | Discontinued |
0.641 | Remote Similarity | NPD9259 | Approved |
0.641 | Remote Similarity | NPD9257 | Approved |
0.6406 | Remote Similarity | NPD3134 | Approved |
0.6403 | Remote Similarity | NPD5157 | Phase 1 |
0.6403 | Remote Similarity | NPD5159 | Phase 2 |
0.6403 | Remote Similarity | NPD5158 | Clinical (unspecified phase) |
0.64 | Remote Similarity | NPD4110 | Phase 3 |
0.64 | Remote Similarity | NPD4109 | Clinical (unspecified phase) |
0.6395 | Remote Similarity | NPD1510 | Phase 2 |
0.6393 | Remote Similarity | NPD6049 | Phase 2 |
0.6393 | Remote Similarity | NPD6048 | Clinical (unspecified phase) |
0.6387 | Remote Similarity | NPD2651 | Approved |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.